Genmab — Juli 2020
-
De tidlige nedlukninger i Q2 i Europa må have påvirket ROW kraftigt i negativ retning.
-
Patienter med cancer får vel ikke mindre behov for medicin og behandling, selv under en coronakrise?
-
As we continue our journey toward becoming a fully integrated biotech company, we welcome Brad Bailey as Genmab’s first US General Manager. Brad will lead the Genmab US market organization and build the US team to enable Commercialization success. #Genmabnews
-
Senior Vice President https://twitter.com/Genmab/status/1285935918575222784
-
Du mener at de bare får lov til at sejle deres egen sø?
-
Usmageligt! Hvis man vælger kræftsyge patienter fra!
-
Ved hvor vigtigt det er at behandling for cancer kører fuldstændig straight, hvis man skal overleve!
-
Aabforever...Det har der været skrevet en del i medierne under nedlukningen.
-
Det er rigtigt Helge. Det er altid naboen det går ud over...lige indtil man selv står midt i det.
-
Jeg tænker på hele Europa i relation til ROW.
-
Netop.
-
this was in the Lancet on that recently Fewer cancer diagnoses during the COVID-19 epidemic in the
Netherlands https://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(20)30265-5.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind